HealthQuill Articles by: HealthQuill
Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results
Drugs Health Medical

J&J stops trials on drug to treat muscle-invasive bladder cancer

Johnson and Johnson discontinued a study of an investigational drug to treat bladder cancer after it failed to yield desired results

Read More
The FDA has warned consumers against the use of fast-act rheum and UA-Block capsules used to treat inflammation and joint pains as it contains substances that raise blood sugar, heart attacks, and stroke.
Drugs Health Medical

Balancing gut bacteria can reduce inflammation in rheumatoid arthritis

HQ Team October 7, 2024: Rheumatoid arthritis (RA), an autoimmune disease that causes joint and bone inflammation, is affected by gut bacteria. Researchers

Read More
UK-based DIOSynVax, a biotechnology company, has developed a single candidate vaccine neutralizing immune responses across the spectrum of very diverse H5 subtypes of influenza viruses.
Drugs Health Medical

UK’s DIOSynVax develops single candidate vaccine for bird flu virus

UK-based DIOSynVax, a biotechnology company, has developed a single candidate vaccine neutralizing immune responses across the spectrum of very diverse H5 subtypes of influenza

Read More
cigarette smoke
Drugs Health Pharma

US drug regulator clears Qnovia’s nicotine inhaler for clinical testing

HQ Team October 7, 2024: The US Food and Drug Administration (FDA)has cleared Qnovia Inc’s nicotine inhaler RespiRx for clinical trial. The US

Read More
British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic disorder.
Drugs Health Medical

AstraZeneca in $1.92 million deal with HK-listed CSPC Pharmaceutical

British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic

Read More
Extreme warming in the Antarctic Peninsula has increased the vegetation cover in the region by more than tenfold over the last four decades, according to researchers from the universities of Exeter and Hertfordshire and the British Antarctic Survey.
Climate Health Medical

Vegetation cover in Antarctic Peninsula increases 10-fold in last four yrs: Study

Extreme warming in the Antarctic Peninsula has increased the vegetation cover in the region by more than tenfold over the last four decades,

Read More
he Democratic Republic of the Congo has started mpox vaccination aiding efforts to halt the spread of the viral disease, according to the World Health Organization.
Drugs Health Medical

Congo begins mpox vaccination in eastern region, roll-outs in 11 provinces

he Democratic Republic of the Congo has started mpox vaccination aiding efforts to halt the spread of the viral disease, according to the

Read More
More than 200 people were murdered worldwide last year while trying to protect their lands and the environment from corporations, governments and non-state actors, according to a Global Witness report.
Climate Health Pharma

More than 200 land defenders died globally in 2023, Colombia deadliest

More than 200 people were murdered worldwide last year while trying to protect their lands and the environment from corporations, governments and non-state

Read More
Global corporations worldwide are now adapting to a "new normal," where WFH is becoming standard practice, either fully or partially. While seeking a "new normal," there is growing concern about mental health outcomes associated with WFH.  A study examining WFH experiences during lockdown found that most respondents reported more positive than negative experiences. 
Drugs Health Medical Opinion

Opinion: Work from home debate rages on as Mental Health Day nears

By Aparna S As we inch toward October 10, Mental Health Day, the ‘Workplace Mental Health’ theme for 2024 needs to be put

Read More
Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.
Drugs Health Pharma

Johnson & Johnson stops mid-stage trial of drug for dengue prevention

Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.

Read More